Literature DB >> 19602463

Gene amplification in myeloid leukemias elucidated by fluorescence in situ hybridization.

Kathleen C Rayeroux1, Lynda J Campbell.   

Abstract

Gene amplification in hematologic malignancies is uncommon. When karyotyping leukemia cells, gene amplification is generally seen as double-minute (dmin) chromosomes and homogeneously staining regions (hsr). One of the more commonly amplified regions is MYC at 8q24.21, but amplification of MLL at 11q23 and regions on 9p, 19q, and elsewhere on 11q have been reported. Increased copy number of these genes has been associated with poor prognosis. Over an 11-year period, we identified 31 cases of possible gene amplification, 27 of which had enough sample material for further investigations. A total of 17 cases had dmin only, 13 cases had hsr only, and 1 case had both dmin and hsr in the karyotype. Fluorescence in situ hybridization (FISH) analysis identified amplification of MYC in 12 cases, all on dmin, and amplification of MLL in eight cases, all on hsr. Regions other than MYC and MLL were amplified in eight cases and, using multicolor FISH and multicolor banding, we identified a number of novel regions of amplification: 13q11 approximately q12.1, 15q26.1 approximately q26.3, and 17q12. We also identified one case where two different chromosomal regions were simultaneously amplified in the same cell line.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19602463     DOI: 10.1016/j.cancergencyto.2009.04.006

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  5 in total

1.  Colorimetric in situ hybridization identifies MYC gene signal clusters correlating with increased copy number, mRNA, and protein in diffuse large B-cell lymphoma.

Authors:  Carlo Valentino; Samantha Kendrick; Nathalie Johnson; Randy Gascoyne; Wing C Chan; Dennis Weisenburger; Rita Braziel; James R Cook; Raymond Tubbs; Elias Campo; Andreas Rosenwald; German Ott; Jan Delabie; Elaine Jaffe; Wenjun Zhang; Patrick Brunhoeber; Hiro Nitta; Tom Grogan; Lisa Rimsza
Journal:  Am J Clin Pathol       Date:  2013-02       Impact factor: 2.493

Review 2.  MYC oncogene in myeloid neoplasias.

Authors:  M Dolores Delgado; Marta Albajar; M Teresa Gomez-Casares; Ana Batlle; Javier León
Journal:  Clin Transl Oncol       Date:  2012-08-22       Impact factor: 3.405

3.  Amplification of c-MYC and MLL Genes as a Marker of Clonal Cell Progression in Patients with Myeloid Malignancy and Trisomy of Chromosomes 8 or 11.

Authors:  S Angelova; M Jordanova; B Spassov; V Shivarov; M Simeonova; I Christov; P Angelova; K Alexandrova; A Stoimenov; V Nikolova; I Dimova; P Ganeva; N Tzvetkov; E Hadjiev; S Toshkov
Journal:  Balkan J Med Genet       Date:  2011-12       Impact factor: 0.519

4.  Direct and indirect targeting of MYC to treat acute myeloid leukemia.

Authors:  Sam Brondfield; Sushma Umesh; Alexandra Corella; Johannes Zuber; Amy R Rappaport; Coline Gaillard; Scott W Lowe; Andrei Goga; Scott C Kogan
Journal:  Cancer Chemother Pharmacol       Date:  2015-05-09       Impact factor: 3.333

5.  Profile of Chromosomal Alterations, Chromosomal Instability and Clonal Heterogeneity in Colombian Farmers Exposed to Pesticides.

Authors:  María Paula Meléndez-Flórez; Duvan Sebastián Valbuena; Sebastián Cepeda; Nelson Rangel; Maribel Forero-Castro; María Martínez-Agüero; Milena Rondón-Lagos
Journal:  Front Genet       Date:  2022-02-24       Impact factor: 4.599

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.